Pulmonary Drug Delivery Systems Market Revenue 2024 to 2034
Pulmonary Drug Delivery Systems Market Revenue 2024 to 2034
The pulmonary drug delivery systems market will increase from USD 55.74 Bn in 2024 to USD 87.73 Bn by 2034, at a 4.64% CAGR, supported by asthma/COPD prevalence, inhaler innovations, and rising demand for self-administered therapies.
Report ID: 10687
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 55.74 Bn
Forecast Year,
USD 87.73 Bn
CAGR, 2025 -
4.64%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Pulmonary Drug Delivery Systems Market Size Analysis
Pulmonary Drug Delivery Systems Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhalers | 26.15 | 27.47 | 28.46 | 30.21 | 31.60 | 32.66 | 34.36 | 35.27 | 37.29 | 39.56 | 42.72 |
| Nebulizers | 23.83 | 24.88 | 26.35 | 27.10 | 27.99 | 30.36 | 31.29 | 32.50 | 34.02 | 36.72 | 38.18 |
| Accessories | 5.76 | 5.98 | 6.23 | 6.55 | 7.24 | 6.90 | 7.52 | 8.79 | 8.82 | 7.57 | 6.84 |
Pulmonary Drug Delivery Systems Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asthma | 20.49 | 21.62 | 22.39 | 22.77 | 24.67 | 25.30 | 27.06 | 28.92 | 29.20 | 29.08 | 30.47 |
| COPD | 23.53 | 24.44 | 25.80 | 27.73 | 27.98 | 29.88 | 32.10 | 31.93 | 34.06 | 36.49 | 37.29 |
| Other Respiratory | 11.72 | 12.27 | 12.83 | 13.37 | 14.18 | 14.74 | 14.02 | 15.72 | 16.87 | 18.28 | 19.97 |
Pulmonary Drug Delivery Systems Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 19.46 | 20.33 | 21.54 | 22.64 | 23.58 | 24.29 | 25.49 | 26.81 | 26.06 | 30.75 | 32.41 |
| Homecare | 15.66 | 16.38 | 17.48 | 17.78 | 17.86 | 20.98 | 20.67 | 21.09 | 23.41 | 21.91 | 22.45 |
| Others | 20.62 | 21.61 | 22.01 | 23.44 | 25.38 | 24.66 | 27.01 | 28.68 | 30.65 | 31.18 | 32.87 |
Pulmonary Drug Delivery Systems Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.69 | 1.93 | 1.55 | 1.83 | 2.06 | 2.48 | 0.85 | 3.81 | 1.85 | 3.74 | 0.90 |
| Europe | 13.95 | 14.65 | 15.48 | 15.83 | 16.67 | 16.34 | 17.95 | 18.78 | 19.11 | 21.25 | 22.94 |
| Asia Pacific | 28.97 | 29.95 | 31.85 | 33.60 | 34.17 | 37.17 | 38.70 | 38.02 | 42.11 | 41.99 | 46.28 |
| Latin America | 10.65 | 11.16 | 12.06 | 12.49 | 12.58 | 12.86 | 15.59 | 15.19 | 14.29 | 16.78 | 16.67 |
| Middle East & Africa | 0.49 | 0.63 | 0.10 | 0.12 | 1.35 | 1.07 | 0.08 | 0.76 | 2.75 | 0.08 | 0.94 |
Pulmonary Drug Delivery Systems Market
Pulmonary Drug Delivery Systems Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
